Publications by Fellows

John A. Ozimek, DO


  • Wang ET, Ozimek JA, Greene N, Ramos L, Vyas N, Kilpatrick SJ, Pisarska MD. Impact of fertility treatment on severe maternal morbidity. Fertil Steril. 2016 Aug;106(2):423-426.
  • Ozimek JA, Eddins RM, Greene N, Karagyozyan D, Pak S, Wong M, Zakowski M, Kilpatrick SJ. Opportunities for improvement in care among women with severe maternal morbidity. Am J Obstet Gynecol. 2016 Oct;215(4):509.e1-6.

Kathryn Jones Sharma, MD


  • Sharma KJ, Rodriguez M, Kilpatrick SJ, Greene N, Aghajanian P. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low. Hypertens Pregnancy. 2016;35(1):123-128.
  • Sharma K, Afshar YR, Bairey-Merz CN, Tapson V, Zakowski M, Kilpatrick SJ. Guidelines and consensus: statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulm Circ. 2016 Mar;6(1):143.
  • Sharma KJ, Greene N, Kilpatrick SJ. Oral labetalol compared to oral nifedipine for postpartum hypertension: A randomized controlled trial. Hypertens Pregnancy. 2017 Feb;36(1):44-47.
  • Sharma KJ, Kilpatrick SJ. Postpartum Hypertension: Etiology, Diagnosis, and Management. Obstet Gynecol Surv. 2017 Apr;72(4):248-252.
  • Sharma KJ, Esakoff TF, Guillet A, Burwick RM, Caughey AB. Pregnancies complicated by both preeclampsia and growth restriction between 34 and 37 weeks' gestation are associated with adverse perinatal outcomes. J Matern Fetal Neonatal Med. 2017 Oct;30(19):2342-2345.

Steve Rad, MD


  • Rad S, Ogunyemi D. Using the health-care matrix to teach and improve patient safety culture in an OB/GYN residency training program. J Patient Saf. 2012 Dec;8(4):177-181.
  • Ogunyemi D, Xu J, Mahesan AM, Rad S, Kim E, Yano J, Alexander C, Rotter JI, Chen YD. Differentially expressed genes in adipocytokine signaling pathway of adipose tissue in pregnancy. J Diabetes Mellitus. 2013 May;3(2):86-95.
  • Johnston R, Fong A, Lovell S, Sobolewski PS, Rad S, Turner A. Demographic and Obstetric Outcomes of Pregnancies conceived by Assisted Reproductive Technology (ART) compared to Non-ART Pregnancies. JBRA Assist Reprod. 2015 Feb 1;19(1):16-20.
  • Williams J 3rd, Rad S, Beauchamp S, Ratousi D, Subramaniam V, Farivar S, Pisarska MD. Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing. Am J Obstet Gynecol. 2015 Jul;213(1):102.e1-6.
  • Esakoff TF, Rad S, Burwick RM, Caughey AB. Predictors of eclampsia in California. J Matern Fetal Neonatal Med. 2016;29(10):1531-1535.
  • Rad S, Beauchamp S, Morales C, Mirocha J, Esakoff TF. Defining fetal growth restriction: abdominal circumference as an alternative criterion. J Matern Fetal Neonatal Med. 2017 Aug 17:1-6.